Connect your AI

EXOZ EXOZ Payments for finance leases

Payments for finance leases at other companies

GevoGEVO

$140K-69.4%

Ginkgo BioworksDNA

$19K-90.8%

NAG

Niagen Bioscience, Inc. Common StockNAGE

$0-100%

West Pharmaceutical ServicesWST

$300K+50.0%

Other financials

Income statement

Revenue$17.5K—

Operating income-$2.4M-22.4%

Net income-$2.4M-27.7%

EPS (diluted)-$0.28-27.3%

Balance sheet

Cash & equivalents$1.4M-83.0%

Total debt$1.2M-8.8%

Total equity$1.5M-82.8%

Total assets$4.0M-65.1%

Cash flow

Operating cash flow-$1.5M-34.5%

CapEx$57.6K+85.5%

Free cash flow-$1.6M-35.8%

Valuation

Market cap$76.8M-5.6%

Enterprise value$76.57M+1.0%

P/S1,096.1×—

Profitability

Operating margin-14,489.6%—

Net margin-2,909.1%—

FCF margin-10,117.8%—

Returns & leverage

Return on equity-185.8%—

Debt / equity0.8×+0.6×

Current ratio1.3×-5.2×

Where this comes from

Reported directly by EXOZ in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeasePrincipalPayments.

The official record: EXOZ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about EXOZ's payments for finance leases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is EXOZ's payments for finance leases?: EXOZ (EXOZ) reported payments for finance leases of $12.74K in Q1 2026.
What does payments for finance leases mean?: Principal payments on finance lease obligations, reducing the lease liability on the balance sheet.